Infliximab associated new-onset psoriasis
- PMID: 16485887
Infliximab associated new-onset psoriasis
Abstract
Infliximab infusion is not yet FDA-approved for psoriasis but has been reported to be very effective for plaque psoriasis. We report 2 patients without a history of psoriasis who after administration of infliximab for their inflammatory bowel disease experienced new onset, biopsy confirmed psoriasis.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical